
A Study of Reported Factor IX Use Around the World
Presents data on the reported use of factor IX (FIX) per country. FIX use varies considerably, even among the wealthiest
Year: 2010
Language: English
This resource is also available in: Spanish
Author(s): Gerry Dolan
Format: Document
As their life expectancy approaches that of the general population, people with hemophilia are now facing many of the same health problems. This paper gives healthcare providers an excellent overview of the relationship between hemophilia and age-related diseases such as cardiovascular disease, renal disease, and cancer.

Presents data on the reported use of factor IX (FIX) per country. FIX use varies considerably, even among the wealthiest

An analysis of the global prevalence of hemophilia B, based in large part on the WFH’s Global Survey Data. Prevalence

This monograph highlights the prevalence and devastating impact of pain in hemophilia patients, reviews currently available treatment options, and identifies

A review of the epidemiology, risk factors, treatment, and outcomes of liver cancer associated with chronic hepatitis C infection, with

Presents data on the reported use of factor VIII (FVIII) per country. FVIII use varies considerably, even among the wealthiest

An analysis of the global prevalence of hemophilia A, based in large part on the WFH’s Global Survey Data. Prevalence